PDL BioPharma Inc (NASDAQ:PDLI)

6.68
Delayed Data
As of May 29
 -0.12 / -1.76%
Today’s Change
6.38
Today|||52-Week Range
10.26
-13.36%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for PDL BioPharma Inc have a median target of 7.00, with a high estimate of 8.00 and a low estimate of 6.00. The median estimate represents a +4.79% increase from the last price of 6.68.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Hold stock in PDL BioPharma Inc. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.52
Sales
$137.7M
Reporting Date
Jul 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.00%
 
 
 
 
 
 
Growthannually 13.17%
 
 
 
 
 
 

Sales

Growthquarterly -8.01%
 
 
 
 
 
 
Growthannually -0.29%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account